Life Sciences

Deloitte Insights

Personalized therapies in the Future of Health

Winning with digital medicine products

Deloitte Insights

South Africa economic outlook

Pandemic response needs to be balanced with health equity goals

Although South Africa’s medium-term outlook has improved slightly, much work remains to be done, especially on the health care front. Now, more than ever, the government and private sector need to work together to improve the country’s long-term economic outlook.

Article

Improving care and creating efficiencies

Are physicians ready to embrace digital technologies now?

Deloitte Insights

Biopharma leaders prioritize R&D, technological transformation, and global market presence

Findings from a new survey and analysis of investor calls in the first half of 2020

Article

The future of biopharma

Reimagining traditional business models in 2040

Predictions

Six predictions for China's pharma & health care sector

What changes will COVID-19 drive in China’s health care system?

This piece from Deloitte China outlines potential impacts of COVID-19 on the country’s health care sector

Analysis

2020 Global life sciences outlook

Creating new value | Building blocks for the future

Gene therapies, intelligent drug discovery and development, consumer wearables, telemedicine, and more—what are some of the drivers transforming the life sciences sector? How can biopharma and medtech organizations create new value in 2020, while tackling various challenges? 

Article

The future of aging

What impact might the expansion of health span have on society?

Analysis

2019 Global life sciences outlook

Focus and transform| Accelerating change in life sciences

Analysis

2019 Global Health Care Outlook

Shaping the future

Analysis

2017 Global life sciences outlook

Thriving in today’s uncertain market

Perspectives

Global Health Care Outlook 2017

Making progress against persistent challenges